Abstract Details

Title Stroke-Associated Pneumonia (SAP): Risk Factors for Its Development and Affect on Stroke Outcome

Topic Cerebrovascular Disease and Interventional Neurology

Presentation(s) (-)

Poster/Presentation
Number 006

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Olga Finlayson, MD (Mackenzie Health)	No disclosure on file
Moira Kapral, MD (Toronto General Hospital)	The institution of Moira Kapral, MD has received research support from Heart and Stroke Foundation of Canada, Canadian Institutes of Health Research.
	No disclosure on file
	No disclosure on file
	No disclosure on file
Daniel H. Selchen, MD (St.Michael'S Hospital)	Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva.

��ɫ����